Cargando…
SAT-454 Isolated ACTH Deficiency Due to Pembrolizumab
Introduction Pembrolizumab, a humanized anti-programmed death -1 antibody has been used in the treatment of several malignancies with improved prognosis, but it has been associated with several immune related adverse effects, particularly endocrinopathy. We report a case of pembrolizumab induced iso...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Endocrine Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552007/ http://dx.doi.org/10.1210/js.2019-SAT-454 |